Get the Stockscreener App
1.74
1.16%
0.02
Pre-market:
1.76
0.02
+1.15%
Health Catalyst Inc stock is traded at $1.74, with a volume of 706.93K.
It is up +1.16% in the last 24 hours and up +9.43% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$1.72
Open:
$1.73
24h Volume:
706.93K
Relative Volume:
0.77
Market Cap:
$130.95M
Revenue:
$302.48M
Net Income/Loss:
$-265.26M
P/E Ratio:
-0.4682
EPS:
-3.716
Net Cash Flow:
$-2.76M
1W Performance:
-3.33%
1M Performance:
+9.43%
6M Performance:
+58.90%
1Y Performance:
-39.16%
1-Day Range:
$1.71
$1.76
1-Week Range:
$1.71
$1.89
52-Week Range:
$0.9551
$3.615
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.74 | 130.95M | 302.48M | -265.26M | -2.76M | -3.716 |
VEEV
Veeva Systems Inc
|
274.84 | 44.50B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
82.24 | 14.93B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.02 | 11.08B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
84.11 | 10.96B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
91.98 | 7.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region - GlobeNewswire Inc.
Wells Fargo raises Health Catalyst price target to $1.75 - scanx.trade
Simeon Kohl Bought 118% More Shares In Health Catalyst - webull.com
Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks - Yahoo Finance
Health Catalyst stock trades near lows as small-cap sentiment weakens - AD HOC NEWS
Health Catalyst Q2FY26 Results: Revenue beats guidance, debt retired - scanx.trade
Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Health Catalyst CEO Kohl Simeon Granted 2.75M Shares in Equity Award and Acquires Additional Stock - kalkinemedia.com
Health Catalyst Adds Tami Reller to Board for Growth - The Globe and Mail
Health Catalyst reports inducement awards - Medical Buyer
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Health Catalyst appoints Tami Reller to board of directors By Investing.com - Investing.com Australia
Health Catalyst appoints Tami Reller to board of directors - Investing.com
Health Catalyst appoints Tami Reller to board a... - Pluang
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller - PR Newswire
Health Catalyst Appoints Simeon Kohl As CEO And President - Pulse 2.0
Health Catalyst CEO Albert Benjamin Forfeits 35,244 Shares at $1.67, Retains 1.39 Million Shares - Kalkine Media
Mandatory tax sale by Health Catalyst (HCAT) CEO - Stock Titan
Planned $59K stock sale at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Health Catalyst appoints new CEO - healthcaredive.com
The Escalator: Inizio, Health Catalyst, Eversana and more - Medical Marketing and Media
Canaccord Genuity Sticks to Its Hold Rating for Health Catalyst (HCAT) - The Globe and Mail
Palogic Value Management Increases Activist Stake to 7.1% in Health Catalyst (NASDAQ: HCAT) - Kalkine Media
Palogic Value Management Secures 7.1% Activist Stake in Health Catalyst (NASDAQ: HCAT) - Kalkine Media
Health Catalyst appoints Simeon Kohl as new CEO - The Globe and Mail
symbol__ Stock Quote Price and Forecast - cnn.com
Health Catalyst Names Simeon Kohl As CEO And President And Ben Albert To Become Chief Business Officer - Pulse 2.0
Investor group asks for clearer plan at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Health Catalyst taps new CEO - modernhealthcare.com
Health Catalyst, Inc. Announces CEO Changes - marketscreener.com
Health Catalyst Appoints Simeon Kohl as CEO, Ben Albert Steps Down - Minichart
Health Catalyst names Simeon Kohl as new CEO By Investing.com - Investing.com Canada
The Next Healthcare Catalyst Hunt Is On — Why Knight Therapeutics, Inc. (TSX:GUD) Could Draw Attention - kalkine.ca
Health Catalyst names Simeon Kohl as new CEO - Investing.com
Health Catalyst gets a new chief after he led a healthcare company through a roughly $670 million sale. - Stock Titan
The Next Healthcare Catalyst Hunt Is On — Why HLS Therapeutics, Inc. (HLS) Could Draw Attention - kalkine.ca
Health Catalyst Grants Insider Julie Larson-Green 9,766 Shares at No Cost (NASDAQ: HCAT) - Kalkine Media
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Officer Alger Jason - Moomoo
Health Catalyst | 4: Statement of changes in beneficial ownership of securities-Director Larson-Green Julie - Moomoo
Health Catalyst (HCAT) CEO offloads 321 shares to cover taxes - Stock Titan
Health Catalyst (HCAT) CFO sells shares to cover RSU taxes - Stock Titan
Equity grant lifts Health Catalyst (HCAT) director to 185K shares - Stock Titan
Tax-driven stock sale by Health Catalyst (HCAT) legal chief - Stock Titan
Health Catalyst (NASDAQ: HCAT) officer schedules new stock sale after June trades - Stock Titan
Health Catalyst (HCAT) insider plans $30,618.80 stock sale - Stock Titan
Health Catalyst (NASDAQ: HCAT) executive lines up stock sale; size and timing inside - Stock Titan
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst to present at Wells Fargo healthcare conference - scanx.trade
Health Catalyst Market Sentiment - Benzinga España
Health Catalyst Inc (HCAT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Investors Are Hunting for the Next Healthcare Catalyst: Could HLS Therapeutics, Inc (HLS) Deliver? - kalkine.ca
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):